| Product Code: ETC9971265 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Neglected Tropical Diseases Treatment Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Neglected Tropical Diseases Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Neglected Tropical Diseases Treatment Market - Industry Life Cycle |
3.4 United States (US) Neglected Tropical Diseases Treatment Market - Porter's Five Forces |
3.5 United States (US) Neglected Tropical Diseases Treatment Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 United States (US) Neglected Tropical Diseases Treatment Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 United States (US) Neglected Tropical Diseases Treatment Market Revenues & Volume Share, By Administration, 2021 & 2031F |
3.8 United States (US) Neglected Tropical Diseases Treatment Market Revenues & Volume Share, By End use, 2021 & 2031F |
4 United States (US) Neglected Tropical Diseases Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and advocacy efforts for neglected tropical diseases in the US |
4.2.2 Government initiatives and funding support for research and development of treatments |
4.2.3 Growing partnerships between pharmaceutical companies and non-profit organizations to address neglected tropical diseases |
4.3 Market Restraints |
4.3.1 Limited access to healthcare in certain regions of the US |
4.3.2 Regulatory challenges and approval processes for new treatments |
4.3.3 Lack of financial incentives for pharmaceutical companies to invest in neglected tropical diseases treatments |
5 United States (US) Neglected Tropical Diseases Treatment Market Trends |
6 United States (US) Neglected Tropical Diseases Treatment Market, By Types |
6.1 United States (US) Neglected Tropical Diseases Treatment Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Neglected Tropical Diseases Treatment Market Revenues & Volume, By Disease Type, 2021- 2031F |
6.1.3 United States (US) Neglected Tropical Diseases Treatment Market Revenues & Volume, By Mediterranean Fever, 2021- 2031F |
6.1.4 United States (US) Neglected Tropical Diseases Treatment Market Revenues & Volume, By Ebola Virus Infection, 2021- 2031F |
6.1.5 United States (US) Neglected Tropical Diseases Treatment Market Revenues & Volume, By Chagas Disease, 2021- 2031F |
6.1.6 United States (US) Neglected Tropical Diseases Treatment Market Revenues & Volume, By Zika Virus Infection, 2021- 2031F |
6.1.7 United States (US) Neglected Tropical Diseases Treatment Market Revenues & Volume, By Chikungunya, 2021- 2031F |
6.1.8 United States (US) Neglected Tropical Diseases Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) Neglected Tropical Diseases Treatment Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Neglected Tropical Diseases Treatment Market Revenues & Volume, By Drugs, 2021- 2031F |
6.2.3 United States (US) Neglected Tropical Diseases Treatment Market Revenues & Volume, By Vaccine, 2021- 2031F |
6.3 United States (US) Neglected Tropical Diseases Treatment Market, By Administration |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Neglected Tropical Diseases Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 United States (US) Neglected Tropical Diseases Treatment Market Revenues & Volume, By Injectable, 2021- 2031F |
6.4 United States (US) Neglected Tropical Diseases Treatment Market, By End use |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Neglected Tropical Diseases Treatment Market Revenues & Volume, By Clinical Labs, 2021- 2031F |
6.4.3 United States (US) Neglected Tropical Diseases Treatment Market Revenues & Volume, By Hospitals /Clinics, 2021- 2031F |
6.4.4 United States (US) Neglected Tropical Diseases Treatment Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
7 United States (US) Neglected Tropical Diseases Treatment Market Import-Export Trade Statistics |
7.1 United States (US) Neglected Tropical Diseases Treatment Market Export to Major Countries |
7.2 United States (US) Neglected Tropical Diseases Treatment Market Imports from Major Countries |
8 United States (US) Neglected Tropical Diseases Treatment Market Key Performance Indicators |
8.1 Number of patients receiving treatment for neglected tropical diseases in the US |
8.2 Funding allocated by the government and non-profit organizations for research and development |
8.3 Number of partnerships formed between pharmaceutical companies and non-profit organizations to address neglected tropical diseases |
9 United States (US) Neglected Tropical Diseases Treatment Market - Opportunity Assessment |
9.1 United States (US) Neglected Tropical Diseases Treatment Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 United States (US) Neglected Tropical Diseases Treatment Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 United States (US) Neglected Tropical Diseases Treatment Market Opportunity Assessment, By Administration, 2021 & 2031F |
9.4 United States (US) Neglected Tropical Diseases Treatment Market Opportunity Assessment, By End use, 2021 & 2031F |
10 United States (US) Neglected Tropical Diseases Treatment Market - Competitive Landscape |
10.1 United States (US) Neglected Tropical Diseases Treatment Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Neglected Tropical Diseases Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here